Joincare Pharmaceutical Group Industry Co., Ltd.

Roche Holding AG ’s Xofluza (baloxavir marboxil) stands to strengthen its position in the influenza treatment market with new data showing it can reduce transmission of the virus among people living i

Chinese drug makers are upping their game in the race to develop a homegrown follower of Shionogi & Co. Ltd. and Roche Holding AG ’s oral influenza antiviral Xofluza (baloxavir marboxil), as Joinc

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Junshi Allies With Rxilient On JV

Top pharma and biotech executives fared relatively poorly in 2022 and among all sectors represented in the just-released ranking of the world's wealthiest people, biotech was among the worst performin